James Mirabile
Obstetrics & Gynecology · Overland Park, KSNPI 1588608855
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 559 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 40.2% of the total. Reporting peaked in 2021 at $2,156 and has fallen 77.2% since, to $491 in 2025. Among obstetrics & gynecology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 559 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Pfizer$1K
- Galderma Laboratories, L.p.$630
- Avion Pharmaceuticals$525
- Mayne Pharma Commercial LLC$437
- Sumitomo Pharma America, Inc.$299
- plus $2K from 28 others
What the payments were for
- Food & beverage$8,47999%
- Education$1221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 224 | $3,457 |
| Pfizer | 81 | $1,030 |
| Galderma Laboratories, L.p. | 31 | $630 |
| Avion Pharmaceuticals | 36 | $525 |
| Mayne Pharma Commercial LLC | 33 | $437 |
| Sumitomo Pharma America, Inc. | 18 | $299 |
| Eisai Inc. | 13 | $227 |
| Astellas Pharma US Inc | 14 | $225 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $220 |
| Lilly USA, LLC | 9 | $151 |
| Myovant Sciences Inc. | 10 | $150 |
| Therapeuticsmd, Inc. | 8 | $137 |
| Urovant Sciences Inc | 8 | $119 |
| Amgen | 7 | $113 |
| Ironwood Pharmaceuticals, Inc | 8 | $112 |
| Millicent US Inc | 4 | $72 |
| Bausch Health US, LLC | 5 | $67 |
| Merz North America, Inc. | 1 | $62 |
| Virtus Pharmaceuticals LLC | 3 | $60 |
| Endo Pharmaceuticals Inc. | 4 | $57 |
| Hologic Sales And Service, LLC | 3 | $57 |
| Exeltis, USA Inc. | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Evofem Biosciences, Inc. | 3 | $48 |
| AMAG Pharmaceuticals, Inc. | 2 | $30 |
| Acelrx Pharmaceuticals, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Assertio Therapeutics, Inc. | 2 | $23 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
| Bayer | 1 | $11 |
How this compares
$8,601 in reported general payments places this provider in the 95th percentile of 302 obstetrics & gynecology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 25 | $6,186 |
| ProgesteroneProgesterone, Micronized | 163 | $5,092 |
| Estradiol | 118 | $3,863 |
| Levothyroxine Sodium | 191 | $1,525 |
| Armour ThyroidThyroid,pork | 18 | $1,413 |
| Spironolactone | 126 | $1,249 |
| SynthroidLevothyroxine Sodium | 21 | $1,214 |
| Butalbital-AcetaminophenButalbital/Acetaminophen | 11 | $1,090 |
| Estradiol (Twice Weekly)Estradiol | 23 | $1,051 |
| Bupropion XlBupropion Hcl | 45 | $1,017 |
| Liothyronine Sodium | 12 | $673 |
| ValacyclovirValacyclovir Hcl | 16 | $572 |
| Zolpidem Tartrate | 91 | $446 |
| Acyclovir | 36 | $427 |
| Cephalexin | 13 | $264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $137 | $6,18625 claims |
| AbbVieArmour Thyroid, Synthroid | $3,457 | $2,62639 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 302 obstetrics & gynecology providers in Kansas.
Other obstetrics & gynecology in Overland Park
- Kimberly SwanOverland Park$123K
- Errick ArroyoOverland Park$7K
- Bridget WebbOverland Park$5K
- Joseph HeitOverland Park$5K
- Sharon MaturoOverland Park$4K
- Emily MindermanOverland Park$4K
- Rebeka WeberOverland Park$4K
- Betsy StanderOverland Park$4K
- Phaedra LombardOverland Park$4K
- Crystal NewbyOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.